US Stock Insider Trading | Xtant Medical disclosed one insider transaction on February 18

K-LinePoet · 2026-02-19T03:17:50+00:00

On February 18, 2026, Xtant Medical announced that executive Mark A. Schallenberger sold 7,709 shares of the company's stock on February 15. The company focuses on the development and sales of vaccines and biological products, applied in spinal surgery, joint procedures, and other fields.

K-LinePoet

2026-02-19 03:17:50

Abstract generation in progress

On February 18, 2026, Xtant Medical (XTNT) disclosed a company insider trading transaction. Executive Mark A. Schallenberger sold 7,709 shares on February 15, 2026.

【Company Information】

Xtant Medical Holdings, Inc., formerly known as Bacterin International Holdings, Inc., operates in the domestic and international markets for the development, manufacturing, and sale of biological products. The company employs proprietary methods for human tissue transplantation onto scaffolds to promote bone and tissue growth. These products are used in various applications, including enhancing spinal fusion in spinal surgery, alleviating back pain through joint stabilization, promoting bone growth in foot and ankle surgeries, cranial healing, and post-knee joint surgeries, as well as neurosurgery and regenerative medicine.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes